Evidence map›Paper›PMID 36297177›Full record

ReviewPathogens (Basel, Switzerland)2022

Application and Development of Biocontrol Agents in China.

Jiaxuan Meng, Xiuyu Zhang, Xingshan Han, Ben Fan

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Pathogenic effects ofApplied and environmental microbiology · 2026
    Article
  2. Laboratory screening and field validation ofFrontiers in microbiology · 2026
    Article
  3. Article
  4. Identification of the Antagonistic FungusJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Biocontrol potential of endophyticFrontiers in microbiology · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiaxuan MengCo-Innovation Center for Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing 210037, China.
Xiuyu ZhangCo-Innovation Center for Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0002-8678-8446
Xingshan HanCo-Innovation Center for Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing 210037, China.
Ben FanCo-Innovation Center for Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0001-8532-1281

Funding

Nation Natural Science Foundation of China 31970097
6 · The paper itself

Abstract

While the growing population in the world has a large demand for food, agriculture and forestry are currently facing severe challenges due to phytopathogens and pests along with global warming. For half a century chemical pesticides and fertilizers have made a great contribution to agricultural production. However, the excessive use of chemical agents has caused obvious side effects on the environment and the sustainable development of agriculture in the long term. China has recorded one of the fastest economic growths for more than 20 years but at the cost of a seriously polluted environment. Since a decade ago, China has paid increasing attention to environment protection and taken intensified measures for pollution control and ecological restoration. In this context, the biocontrol agent industry in China has experienced a golden decade of rapid development. In this minireview, we will introduce the application and development of microorganism-based biocontrol agents in China over the past two decades.

Indexed as

biocontrol agentChinamicrobial fertilizer

Identifiers

PMID36297177
PMCPMC9609727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.